The economics of CK-MB testing {see comments}.
Wilkerson Group, New York.
E H
EH
Howard
R J
RJ
Easton
D003362:Cost-Benefit Analysis; D003402:Creatine Kinase / Q000032:analysis* / Q000191:economics; D006801:Humans; D007527:Isoenzymes; D009203:Myocardial Infarction / Q000175:diagnosis* / Q000453:epidemiology; D014481:United States